Literature DB >> 28298269

Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.

Zeinab Mokhtari1, Deanna L Gibson2, Azita Hekmatdoost3,4.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in the world, yet the pathogenesis of the disease is not well elucidated. Due to the close anatomic and functional association between the intestinal lumen and the liver through the portal system, it is speculated that the gut microbiome may play a pivotal role in the pathogenesis of NAFLD. Furthermore, diet, which can modulate the gut microbiome and several metabolic pathways involved in NAFLD development, shows a potential tripartite relation between the gut, diet, and the liver. In this review, we summarize the current evidence that supports the association between NAFLD, the gut microbiome, and the role of diet.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  NAFLD; NASH; diet; gut microbiota; nonalcoholic fatty liver disease; probiotics

Mesh:

Substances:

Year:  2017        PMID: 28298269      PMCID: PMC5347097          DOI: 10.3945/an.116.013151

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  155 in total

1.  Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Authors:  Tannaz Eslamparast; Hossein Poustchi; Farhad Zamani; Maryam Sharafkhah; Reza Malekzadeh; Azita Hekmatdoost
Journal:  Am J Clin Nutr       Date:  2014-01-08       Impact factor: 7.045

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women.

Authors:  A Santacruz; M C Collado; L García-Valdés; M T Segura; J A Martín-Lagos; T Anjos; M Martí-Romero; R M Lopez; J Florido; C Campoy; Y Sanz
Journal:  Br J Nutr       Date:  2010-03-08       Impact factor: 3.718

4.  Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons.

Authors:  Anita C E Vreugdenhil; Corine H Rousseau; Thomas Hartung; Jan Willem M Greve; Cornelis van 't Veer; Wim A Buurman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

5.  Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression.

Authors:  João S Teodoro; Anabela P Rolo; Filipe V Duarte; Anabela M Simões; Carlos M Palmeira
Journal:  Mitochondrion       Date:  2008-08-15       Impact factor: 4.160

6.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

7.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

8.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

9.  Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice.

Authors:  Ulrika Axling; Crister Olsson; Göran Molin; Karin Berger; Jie Xu; Céline Fernandez; Sara Larsson; Kristoffer Ström; Siv Ahrné; Cecilia Holm
Journal:  Nutr Metab (Lond)       Date:  2012-11-26       Impact factor: 4.169

10.  Methods for Improving Human Gut Microbiome Data by Reducing Variability through Sample Processing and Storage of Stool.

Authors:  Monika A Gorzelak; Sandeep K Gill; Nishat Tasnim; Zahra Ahmadi-Vand; Michael Jay; Deanna L Gibson
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more
  35 in total

Review 1.  Role and effective therapeutic target of gut microbiota in NAFLD/NASH.

Authors:  Qun Liu; Shousheng Liu; Lizhen Chen; Zhenzhen Zhao; Shuixian Du; Quanjiang Dong; Yongning Xin; Shiying Xuan
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

Review 2.  Butyrate: A Double-Edged Sword for Health?

Authors:  Hu Liu; Ji Wang; Ting He; Sage Becker; Guolong Zhang; Defa Li; Xi Ma
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

Review 3.  Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.

Authors:  Pankaj Prasun; Ilona Ginevic; Kimihiko Oishi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

4.  The association between major dietary patterns with the risk of non-alcoholic fatty liver disease, oxidative stress and metabolic parameters: A case-control study.

Authors:  Fateme Moradi; Seyedeh Parisa Moosavian; Farhang Djafari; Azam Teimori; Zahra Faghih Imani; Amirmansour Alavi Naeini
Journal:  J Diabetes Metab Disord       Date:  2022-03-19

Review 5.  The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease.

Authors:  Yiming Ni; Mengna Lu; Yuan Xu; Qixue Wang; Xinyi Gu; Ying Li; Tongxi Zhuang; Chenyi Xia; Ting Zhang; Xiao-Jun Gou; Mingmei Zhou
Journal:  Front Microbiol       Date:  2022-06-27       Impact factor: 6.064

6.  Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Authors:  Zohreh Karbaschian; Zeinab Mokhtari; Abdolreza Pazouki; Ali Kabir; Mahdi Hedayati; Somayeh Soleymanzadeh Moghadam; Parvin Mirmiran; Azita Hekmatdoost
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

7.  Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial.

Authors:  Marc R Bomhof; Jill A Parnell; Hena R Ramay; Pam Crotty; Kevin P Rioux; Chris S Probert; Saumya Jayakumar; Maitreyi Raman; Raylene A Reimer
Journal:  Eur J Nutr       Date:  2018-05-19       Impact factor: 5.614

8.  Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.

Authors:  Beza Jobira; Daniel N Frank; Laura Pyle; Lori J Silveira; Megan M Kelsey; Yesenia Garcia-Reyes; Charles E Robertson; Diana Ir; Kristen J Nadeau; Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

9.  Obesity Causes Abrupt Changes in the Testicular Microbiota and Sperm Motility of Zebrafish.

Authors:  Yufang Su; Liting He; Zhiyong Hu; Ying Li; Yuan Zhang; Zunpan Fan; Kai Zhao; Huiping Zhang; Chunyan Liu
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 10.  Diet-Regulating Microbiota and Host Immune System in Liver Disease.

Authors:  Jung A Eom; Goo Hyun Kwon; Na Yeon Kim; Eun Ju Park; Sung Min Won; Jin Ju Jeong; Ganesan Raja; Haripriya Gupta; Yoseph Asmelash Gebru; Satyapriya Sharma; Ye Rin Choi; Hyeong Seop Kim; Sang Jun Yoon; Ji Ye Hyun; Min Kyo Jeong; Hee Jin Park; Byeong Hyun Min; Mi Ran Choi; Dong Joon Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.